Tag Archives: Taxotere
![GavelBooks GavelBooks](https://www.foxandfarleylaw.com/wp-content/uploads/2018/01/GavelBooks-150x150.jpg)
First “Bellwether” Taxotere Trials to Begin in 2018-2019
One of the most common side effects of chemotherapy is temporary hair loss. Unfortunately, the manufacturers of certain chemotherapy drugs like docetaxel–marketed by Sanofi-Aventis under the brand name Taxotere–failed to disclose their products may actually cause permanent hair loss. In 2015, the U.S. Food and Drug Administration required Sanofi-Aventis to amend its labeling for… Read More »